Share on Facebook
Share on Twitter
Share on LinkedIn
Share by Email
Print
Carafate Suspension Generic Name & Formulations
Legal Class
Rx
General Description
Sucralfate 1g/10mL.
Pharmacological Class
Cytoprotective agent.
See Also
How Supplied
Tabs—100; Susp—14oz
Manufacturer
Carafate Suspension Indications
Indications
Short-term (up to 8 weeks) treatment of active duodenal ulcer. Maintenance of healed duodenal ulcers (tabs only).
Carafate Suspension Dosage and Administration
Adult
Active: 1g 4 times daily on an empty stomach for 4–8 weeks. Maintenance: 1g 2 times daily.
Children
Not established.
Carafate Suspension Contraindications
Not Applicable
Carafate Suspension Boxed Warnings
Not Applicable
Carafate Suspension Warnings/Precautions
Warnings/Precautions
Susp: administer by oral route only; do not give intravenously. Monitor for glycemia in diabetic patients. Chronic renal failure. Dialysis. Tabs: swallowing impairment (eg, recent or prolonged intubation, tracheostomy, history of aspiration, dysphagia, others). Pregnancy (Cat.B). Nursing mothers.
Carafate Suspension Pharmacokinetics
Elimination
Renal.
Carafate Suspension Interactions
Interactions
Avoid antacids within 30mins of dosing. May reduce absorption of tetracyclines, quinidine, levothyroxine, phenytoin, cimetidine, digoxin, ciprofloxacin, norfloxacin, ketoconazole, ranitidine, theophylline; dose concomitant drugs 2hrs before sucralfate. Additive aluminum load with aluminum-containing antacids. Monitor warfarin.
Carafate Suspension Adverse Reactions
Adverse Reactions
Constipation.
Carafate Suspension Clinical Trials
See Literature
Carafate Suspension Note
Not Applicable
Carafate Suspension Patient Counseling
See Literature
Images
